| Announce Date | 09/30/2025 |
| EPS Normalized Actual | $-0.06 (Miss by $-0.01) |
| EPS GAAP Actual | $-0.06 (Miss by $-0.01) |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.14 |
| EPS GAAP Estimate | $-0.14 |
| Revenue Estimate | $0.002B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2029 | 0.54 | 79.81 | 0.51268 | 0.56203 | 1 |
| Jun 2028 | 4.17307 | 10.33 | 3.9389 | 4.31947 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | -0.75 | -0.75 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 0B | NAN% | 0M |
| FQ2 2025 (Jun 2025) | -0.03 | -0.03 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.03 | -1.56737 | 0B | NAN% | 0M |
| FQ4 2024 (Dec 2024) | -0.03 | -0.03 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.0251 | -1.59659 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.0251 | -0.0251 | 0B | NAN% | 0M |
| FQ3 2017 (Sep 2017) | -0.0149 | -0.0149 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.14
Consensus Revenue Estimates
0.002B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2026 (Mar 2026) | -0.14 | 78.57 | -0.14 | -0.14 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2026 (Mar 2026) | 0B | -- | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | -0.75 | -0.75 | 100% | |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ2 2025 (Jun 2025) | -0.03 | -0.03 | 100% | |
| FQ3 2024 (Sep 2024) | 1.53737 | -0.03 | -1.56737 | 5224.57% |
| FQ4 2024 (Dec 2024) | -0.03 | -0.03 | 100% | |
| FQ1 2024 (Mar 2024) | 1.57149 | -0.0251 | -1.59659 | 6360.92% |
| FQ2 2024 (Jun 2024) | -0.0251 | -0.0251 | 100% | |
| FQ3 2017 (Sep 2017) | -0.0149 | -0.0149 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2017 (Sep 2017) | $0B | $0B | $0M | NAN% |